Proven Effective
and Well-Tolerated


MALARONE is 98% effective in preventing infection with Plasmodium falciparum, the parasite species that is responsible for most malaria deaths. It is approved for use, even in areas where chloroquine resistance has been reported.

MALARONE has been recommended by the Centers for Disease Control and Prevention (CDC) as an option for the prevention of P. falciparum malaria.

MALARONE works by defending your body against infection in both your liver and blood where MALARONE then kills the malaria parasites.


  • The CDC recommends MALARONE as an option to protect against P. falciparum malaria.
  • The Food and Drug Administration has indicated MALARONE is effective in preventing P. falciparum malaria.
  • MALARONE is well-tolerated for just about everyone in your family.
  • In clinical trials, side effects were comparable to those reported by patients taking placebo.







Talk To Your Doctor about protecting your whole family.


 

Important Information

There are four types of malaria. MALARONE is approved for the treatment and prevention of Plasmodium falciparum malaria in adults and children weighing at least 25 lbs.

In studies conducted for the prevention of malaria in adults, the most common side effects possibly attributed to MALARONE versus placebo were headache (5% vs. 7%) and abdominal pain (3% vs. 5%), in pediatric patients, headache (14% vs. 14%), abdominal pain (31% vs. 29%), and vomiting (7% vs. 6%).

MALARONE is not for everyone. You should not take MALARONE if you have severe kidney disease or are allergic to MALARONE or any of its components. If you are pregnant, consult your physician about the risks and benefits of using MALARONE. Rare cases of anaphylaxis following treatment with atovaquone/proguanil (MALARONE) have been reported.